Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports

被引:1
|
作者
Chang, Kai-Po [1 ,2 ]
Wang, John [2 ]
Chang, Chi-Chang [3 ,4 ]
Chu, Yen-Wei [5 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
[2] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[3] Chung Shan Med Univ, Sch Med Informat, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, IT Off, Taichung 402, Taiwan
[5] Natl Chung Hsing Univ, Inst Genom & Bioinformat, 145 Xingda Rd, Taichung 402, Taiwan
[6] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan
[7] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan
[8] Natl Chung Hsing Univ, Biotechnol Ctr, Taichung 402, Taiwan
[9] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung 402, Taiwan
[10] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan
关键词
PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; AMERICAN SOCIETY; IMMUNOHISTOCHEMISTRY; TEXT; RECOMMENDATIONS; POPULATION; PATHWAY;
D O I
10.1155/2020/2654815
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information about the expression status of hormone receptors such as estrogen receptor (ER), progesterone receptor (PR), and Her-2 is crucial in the management and prognosis of breast cancer. Therefore, the retrieval and analysis of hormone receptor expression characteristics in metastatic breast cancer may be valuable in breast cancer study. Herein, we report a text mining tool based on word/phrase matching that retrieves hormone receptor expression data of regional or distant metastatic breast cancer from pathology reports. It was tested on pathology reports at the China Medical University Hospital from 2013 to 2018. The tool showed specificities of 91.6% and 63.3% for the detection of regional lymph node metastasis and distant metastasis, respectively. Sensitivity in immunohistochemical study result extraction in these cases was 98.6% for distant metastasis and 78.3% for regional lymph node metastasis. Statistical analysis on these retrieved data showed significant difference s in PR and Her-2 expressions between regional and metastatic breast cancer, which is compatible with previous studies. In conclusion, our study shows that metastatic breast cancer hormone receptor expression characteristics can be retrieved by text mining. The algorithm designed in this study may be useful in future studies about text mining in pathology reports.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Misdiagnosis of Metastatic Hormone Receptor Positive Breast Cancer: Clinical Consequences and Root Cause Analysis of the Source of Errors
    Lester, Susan
    Li, Lei
    Qian, Xiaohua
    Sholl, Lynette
    MODERN PATHOLOGY, 2019, 32
  • [22] Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancer
    Carlson, Josh J.
    Guzauskas, Gregory F.
    Dann, Robert A.
    Ramsey, Scott D.
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 1309 - 1317
  • [23] SAFETY OF COMBINED EXEMESTANE AND EVEROLIMUS IN POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE METASTATIC BREAST CANCER PATIENTS - A RETROSPECTIVE ANALYSIS
    Gilchrist, Jenny
    Todd, J.
    Kefford, R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 176 - 176
  • [24] Integrated analysis of whole exome sequencing and hormone receptor expression data in endometrioid ovarian cancer
    Hollis, Robert L.
    Thomson, John
    Stanley, Barbara
    Meynert, Alison M.
    Churchman, Michael
    Rye, Tzyvia
    Herrington, C. Simon
    Gourley, Charlie
    CANCER RESEARCH, 2020, 80 (16)
  • [25] Does hormone expression by IHC predict ER pathway activity? An analysis in a metastatic breast cancer patient cohort
    Yang, S-R
    van de Stolpe, A.
    van Brussel, A.
    van Ooijen, H.
    Galimzianova, A.
    Cohn, D. M.
    Beca, F.
    Rubin, D. L.
    Allison, K. H.
    CANCER RESEARCH, 2019, 79 (04)
  • [26] Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study
    Jiang, Xiaofan
    Chen, Guanglei
    Sun, Lisha
    Liu, Chao
    Zhang, Yu
    Liu, Mingxin
    Liu, Caigang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer
    Turner, Nicholas C.
    Liu, Yuan
    Zhu, Zhou
    Loi, Sherene
    Colleoni, Marco
    Loibl, Sibylle
    DeMichele, Angela
    Harbeck, Nadia
    Andre, Fabrice
    Bayar, Mohamed Amine
    Michiels, Stefan
    Zhang, Zhe
    Giorgetti, Carla
    Arnedos, Monica
    Bartlett, Cynthia Huang
    Cristofanilli, Massimo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (14) : 1169 - +
  • [28] Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status
    Omarini, C.
    Kaleci, S.
    Guaitoli, G.
    Bettelli, S.
    Caprera, C.
    Manfredini, S.
    Caggia, F.
    Baschieri, M. C.
    Moscetti, L.
    Maiorana, A.
    Cascinu, S.
    Piacentini, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] Image analysis-based hormone receptor expression of cancer associated fibroblasts is prognostic in breast cancer: a pilot study
    Boyaci, C.
    Hartman, J.
    Acs, B.
    VIRCHOWS ARCHIV, 2024, 485 : S1 - S2
  • [30] Capivasertib: A Novel AKT Inhibitor Approved for Hormone-Receptor-Positive, HER-2-Negative Metastatic Breast Cancer
    Luboff, Alexa J.
    DeRemer, David L.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (12) : 1229 - 1237